MovDisordV3, Main, Exploration, bibRecord, 000719

Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.

Identifieur interne : 000719 ( Main/Exploration ); précédent : 000718; suivant : 000720

Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.

Auteurs : Yoshikuni Mizuno [Japon] ; Masahiro Nomoto ; Tomoyoshi Kondo ; Kazuko Hasegawa ; Miho Murata ; Masahiro Takeuchi ; Junji Ikeda ; Takayuki Tomida ; Nobutaka Hattori

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2013.

RBID : pubmed:23801585

English descriptors

KwdEn :
- Administration, Cutaneous, Age Factors, Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Disease Progression, Double-Blind Method, Endpoint Determination, Female, Humans, Male, Middle Aged, Parkinson Disease (drug therapy), Tetrahydronaphthalenes (administration & dosage), Tetrahydronaphthalenes (adverse effects), Tetrahydronaphthalenes (therapeutic use), Thiophenes (administration & dosage), Thiophenes (adverse effects), Thiophenes (therapeutic use).
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Tetrahydronaphthalenes, Thiophenes.
- chemical , adverse effects : Antiparkinson Agents, Tetrahydronaphthalenes, Thiophenes.
- chemical , therapeutic use : Antiparkinson Agents, Tetrahydronaphthalenes, Thiophenes.
- drug therapy : Parkinson Disease.
- Administration, Cutaneous, Age Factors, Aged, Disease Progression, Double-Blind Method, Endpoint Determination, Female, Humans, Male, Middle Aged.

Abstract

We conducted a randomized, double-blind, placebo-controlled trial to determine the safety and efficacy of transdermal rotigotine at doses up to 16 mg/24 hours in patients with early stage Parkinson's disease (PD) in Japan.

DOI: 10.1002/mds.25537
PubMed: 23801585

Affiliations:

Japon

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.</title>
<author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neuroregeneration, Kitasato University School of Medicine, Sagamihara, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neuroregeneration, Kitasato University School of Medicine, Sagamihara</wicri:regionArea>
<wicri:noRegion>Sagamihara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nomoto, Masahiro" sort="Nomoto, Masahiro" uniqKey="Nomoto M" first="Masahiro" last="Nomoto">Masahiro Nomoto</name>
</author>
<author><name sortKey="Kondo, Tomoyoshi" sort="Kondo, Tomoyoshi" uniqKey="Kondo T" first="Tomoyoshi" last="Kondo">Tomoyoshi Kondo</name>
</author>
<author><name sortKey="Hasegawa, Kazuko" sort="Hasegawa, Kazuko" uniqKey="Hasegawa K" first="Kazuko" last="Hasegawa">Kazuko Hasegawa</name>
</author>
<author><name sortKey="Murata, Miho" sort="Murata, Miho" uniqKey="Murata M" first="Miho" last="Murata">Miho Murata</name>
</author>
<author><name sortKey="Takeuchi, Masahiro" sort="Takeuchi, Masahiro" uniqKey="Takeuchi M" first="Masahiro" last="Takeuchi">Masahiro Takeuchi</name>
</author>
<author><name sortKey="Ikeda, Junji" sort="Ikeda, Junji" uniqKey="Ikeda J" first="Junji" last="Ikeda">Junji Ikeda</name>
</author>
<author><name sortKey="Tomida, Takayuki" sort="Tomida, Takayuki" uniqKey="Tomida T" first="Takayuki" last="Tomida">Takayuki Tomida</name>
</author>
<author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23801585</idno>
<idno type="pmid">23801585</idno>
<idno type="doi">10.1002/mds.25537</idno>
<idno type="wicri:Area/PubMed/Corpus">000864</idno>
<idno type="wicri:Area/PubMed/Curation">000864</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000740</idno>
<idno type="wicri:Area/Ncbi/Merge">003C18</idno>
<idno type="wicri:Area/Ncbi/Curation">003C18</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003C18</idno>
<idno type="wicri:Area/Main/Merge">000719</idno>
<idno type="wicri:Area/Main/Curation">000719</idno>
<idno type="wicri:Area/Main/Exploration">000719</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.</title>
<author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neuroregeneration, Kitasato University School of Medicine, Sagamihara, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neuroregeneration, Kitasato University School of Medicine, Sagamihara</wicri:regionArea>
<wicri:noRegion>Sagamihara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nomoto, Masahiro" sort="Nomoto, Masahiro" uniqKey="Nomoto M" first="Masahiro" last="Nomoto">Masahiro Nomoto</name>
</author>
<author><name sortKey="Kondo, Tomoyoshi" sort="Kondo, Tomoyoshi" uniqKey="Kondo T" first="Tomoyoshi" last="Kondo">Tomoyoshi Kondo</name>
</author>
<author><name sortKey="Hasegawa, Kazuko" sort="Hasegawa, Kazuko" uniqKey="Hasegawa K" first="Kazuko" last="Hasegawa">Kazuko Hasegawa</name>
</author>
<author><name sortKey="Murata, Miho" sort="Murata, Miho" uniqKey="Murata M" first="Miho" last="Murata">Miho Murata</name>
</author>
<author><name sortKey="Takeuchi, Masahiro" sort="Takeuchi, Masahiro" uniqKey="Takeuchi M" first="Masahiro" last="Takeuchi">Masahiro Takeuchi</name>
</author>
<author><name sortKey="Ikeda, Junji" sort="Ikeda, Junji" uniqKey="Ikeda J" first="Junji" last="Ikeda">Junji Ikeda</name>
</author>
<author><name sortKey="Tomida, Takayuki" sort="Tomida, Takayuki" uniqKey="Tomida T" first="Takayuki" last="Tomida">Takayuki Tomida</name>
</author>
<author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Cutaneous</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Disease Progression</term>
<term>Double-Blind Method</term>
<term>Endpoint Determination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Tetrahydronaphthalenes (administration & dosage)</term>
<term>Tetrahydronaphthalenes (adverse effects)</term>
<term>Tetrahydronaphthalenes (therapeutic use)</term>
<term>Thiophenes (administration & dosage)</term>
<term>Thiophenes (adverse effects)</term>
<term>Thiophenes (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Tetrahydronaphthalenes</term>
<term>Thiophenes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Tetrahydronaphthalenes</term>
<term>Thiophenes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Tetrahydronaphthalenes</term>
<term>Thiophenes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Cutaneous</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Disease Progression</term>
<term>Double-Blind Method</term>
<term>Endpoint Determination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We conducted a randomized, double-blind, placebo-controlled trial to determine the safety and efficacy of transdermal rotigotine at doses up to 16 mg/24 hours in patients with early stage Parkinson's disease (PD) in Japan.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><noCountry><name sortKey="Hasegawa, Kazuko" sort="Hasegawa, Kazuko" uniqKey="Hasegawa K" first="Kazuko" last="Hasegawa">Kazuko Hasegawa</name>
<name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name>
<name sortKey="Ikeda, Junji" sort="Ikeda, Junji" uniqKey="Ikeda J" first="Junji" last="Ikeda">Junji Ikeda</name>
<name sortKey="Kondo, Tomoyoshi" sort="Kondo, Tomoyoshi" uniqKey="Kondo T" first="Tomoyoshi" last="Kondo">Tomoyoshi Kondo</name>
<name sortKey="Murata, Miho" sort="Murata, Miho" uniqKey="Murata M" first="Miho" last="Murata">Miho Murata</name>
<name sortKey="Nomoto, Masahiro" sort="Nomoto, Masahiro" uniqKey="Nomoto M" first="Masahiro" last="Nomoto">Masahiro Nomoto</name>
<name sortKey="Takeuchi, Masahiro" sort="Takeuchi, Masahiro" uniqKey="Takeuchi M" first="Masahiro" last="Takeuchi">Masahiro Takeuchi</name>
<name sortKey="Tomida, Takayuki" sort="Tomida, Takayuki" uniqKey="Tomida T" first="Takayuki" last="Tomida">Takayuki Tomida</name>
</noCountry>
<country name="Japon"><noRegion><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000719 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000719 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23801585
   |texte=   Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23801585" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.

Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.